Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $157.36, but opened at $148.4920. Merck KGaA shares last traded at $155.17, with a volume of 1,810 shares changing hands.
Merck KGaA Trading Down 6.2%
The company has a market capitalization of $19.07 billion, a P/E ratio of 22.52 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The business’s 50-day moving average price is $162.16 and its two-hundred day moving average price is $149.60.
Institutional Investors Weigh In On Merck KGaA
Several institutional investors have recently added to or reduced their stakes in the stock. MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Merck KGaA during the second quarter worth about $4,896,000. Puzo Michael J bought a new stake in shares of Merck KGaA in the second quarter worth $2,230,000. Somerville Kurt F acquired a new position in Merck KGaA during the second quarter worth $1,997,000. Pinnacle Holdings LLC acquired a new position in Merck KGaA during the second quarter worth $1,487,000. Finally, North Star Asset Management Inc. bought a new position in Merck KGaA in the second quarter valued at $1,411,000. 0.10% of the stock is owned by institutional investors.
About Merck KGaA
Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.
The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology.
Further Reading
- Five stocks we like better than Merck KGaA
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
- Cashing in on the Qubit: NVIDIA Takes the Quantum Leap
- Ready to Rumble: Anthropic Rings the AI Bell
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
